Fu Yang

11.0k citations

94 papers · 8.6k · 5 hit papers · h-index 37

Impact in

Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 0.5%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Cancer-related gene regulation
- Epigenetics and DNA Methylation

Papers in

Molecular Biology 61
- RNA modifications and cancer 32
- RNA Research and Splicing 15
- Circular RNAs in diseases 13
- Cancer-related gene regulation 7
Cancer Research 42
- Cancer-related molecular mechanisms research 33
- MicroRNA in disease regulation 14

Co-authors: Shuhan Sun (41 shared papers)Weiping Zhou (23 shared papers)Ji‐hang Yuan (14 shared papers)Jinzhao Ma (9 shared papers)Shengxian Yuan (19 shared papers)Yuan Yang (13 shared papers)Fang Wang (8 shared papers)Chuanchuan Zhou (9 shared papers)
Journals: Hepatology (10 papers)Cell Death and Disease (5 papers)Journal of Cellular Biochemistry (3 papers)Cancer Letters (3 papers)Molecular BioSystems (3 papers)
Partner nations: China United States South Korea

In The Last Decade

Fu Yang

90 papers receiving 8.5k citations

Fu Yang's Hit Papers

5 papers align trajectories log scale

Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma 2018 · 574 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Journal of Hepatology
2016 Hepatology
2014 Cancer Cell
2011 Hepatology
2000 Journal of Neuroscience

Peers

Countries citing papers authored by Fu Yang

Since Specialization

Citations

This map shows the geographic impact of Fu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Yang more than expected).

Fields of papers citing papers by Fu Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Yang. The network helps show where Fu Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Fu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fu Yang Line = papers co-authored together Fu Yang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma Cancer Cell ·Ji‐hang Yuan, Fu Yang, Fang Wang, Jinzhao Ma, Yingjun Guo, Qi-fei Tao, Feng Liu, Wei Pan, Tian-tian Wang, Chuanchuan Zhou, Shaobing Wang, Yu-zhao Wang, Yuan Yang, Ning Yang, Weiping Zhou, Guang-Shun Yang, Shuhan Sun Hit paper breakdown →	2014	1279
2	Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease Journal of Neuroscience ·Giselle P. Lim, Fu Yang, Tinyi Chu, Pisin Chen, Walter Beech, Bruce Teter, Thuy Tran, Oliver J. Ubeda, Karen H. Ashe, Sally A. Frautschy, Greg M. Cole Hit paper breakdown →	2000	741
3	METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6‐methyladenosine‐dependent primary MicroRNA processing Hepatology ·Jinzhao Ma, Fu Yang, Chuanchuan Zhou, Feng Liu, Ji‐hang Yuan, Fang Wang, Tiantian Wang, Qingguo Xu, Weiping Zhou, Shuhan Sun Hit paper breakdown →	2016	690
4	Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma Journal of Hepatology ·Jian Yu, Qingguo Xu, Zhenguang Wang, Yuan Yang, Ling Zhang, Jinzhao Ma, Shuhan Sun, Fu Yang, Weiping Zhou Hit paper breakdown →	2018	574
5	Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans Hepatology ·Fu Yang, Ling Zhang, Xisong Huo, Ji‐hang Yuan, Dan Xu, Shengxian Yuan, Nan Zhu, Weiping Zhou, Guang‐Shun Yang, Yu‐Zhao Wang, Jingli Shang, Chunfang Gao, Fengrui Zhang, Fang Wang, Shuhan Sun Hit paper breakdown →	2011	563
6	Repression of the Long Noncoding RNA-LET by Histone Deacetylase 3 Contributes to Hypoxia-Mediated Metastasis Molecular Cell ·Fu Yang, Xisong Huo, Shengxian Yuan, Ling Zhang, Weiping Zhou, Fang Wang, Shuhan Sun	2013	423
7	Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2 Hepatology ·Fang Wang, Ji‐hang Yuan, Shao-Bing Wang, Fu Yang, Sheng-Xian Yuan, Chen Ye, Ning Yang, Wei-Ping Zhou, Wen-Lin Li, Wen Li, Shu-Han Sun	2014	370
8	Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1 Hepatology ·Shengxian Yuan, Jie Wang, Fu Yang, Qi‐fei Tao, Jin Zhang, Lili Wang, Yuan Yang, Hui Liu, Zhen‐guang Wang, Qingguo Xu, Jia Fan, Lei Liu, Shuhan Sun, Weiping Zhou	2015	335
9	Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy Hepatology ·Shengxian Yuan, Fu Yang, Yuan Yang, Qi-fei Tao, Jin Zhang, Gang Huang, Yun Yang, Ruoyu Wang, Sen Yang, Xisong Huo, Ling Zhang, Fang Wang, Shuhan Sun, Weiping Zhou	2012	333
10	Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma Carcinogenesis ·Ling Zhang, Fu Yang, Ji‐hang Yuan, Shengxian Yuan, Weiping Zhou, Xisong Huo, Dan Xu, Hai-shan Bi, Fang Wang, Shuhan Sun	2012	295
11	Long Noncoding RNAs Associated With Liver Regeneration 1 Accelerates Hepatocyte Proliferation During Liver Regeneration By Activating Wnt/β-Catenin Signaling Hepatology ·Dan Xu, Fu Yang, Ji‐hang Yuan, Ling Zhang, Hai-shan Bi, Chuanchuan Zhou, Feng Liu, Fang Wang, Shuhan Sun	2013	165
12	Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a Oncogene ·Feng Liu, J-H Yuan, J-F Huang, Fu Yang, T-T Wang, Jinzhao Ma, L Zhang, C-C Zhou, Fu Wang, Jin Yu, W-P Zhou, S‐H Sun	2016	154
13	The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma Hepatology ·Ji‐hang Yuan, Fu Yang, Bi-feng Chen, Zhi John Lu, Xisong Huo, Weiping Zhou, Fang Wang, Shuhan Sun	2010	152
14	Mir-17-5P Promotes Migration of Human Hepatocellular Carcinoma Cells Through the P38 Mitogen-Activated Protein Kinase-Heat Shock Protein 27 Pathway Hepatology ·Fu Yang, Yixuan Yin, Fang Wang, Yuqi Wang, Ling Zhang, Ying Tang, Shuhan Sun	2010	142
15	Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria Cell Death and Disease ·Ye Wang, Fu Yang, Haichou Zhang, Xiaoyuan Zi, Xinghua Pan, F-H Chen, Wei Luo, Jiayi Li, H.-Y. Zhu, Y-P Hu	2013	138
16	The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production EBioMedicine ·Wei Dong, Zhihui Dai, Fuchen Liu, Xinggang Guo, Chun-mei Ge, Jin Ding, Hui Liu, Fu Yang	2019	135
17	Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer Cell Death and Disease ·Anbang Wang, Yi Bao, Zhenjie Wu, Tangliang Zhao, Dong Wang, Jiazi Shi, Bing Liu, Shuhan Sun, Fu Yang, Linhui Wang, Le Qu	2019	103
18	Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma Oncogene ·Zhipeng Xu, Fu Yang, Dongmin Wei, B Liu, C Chen, Yi Bao, Zhenjie Wu, Deng-Shuang Wu, Haoyue Tan, J Li, J Wang, J Liu, Shuxin Sun, Le Qu, L Wang	2016	98
19	Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma Hepatology ·Chuanchuan Zhou, Fu Yang, Shengxian Yuan, Jinzhao Ma, Feng Liu, Ji‐hang Yuan, Feng‐rui Bi, Kongying Lin, Jianhua Yin, Guangwen Cao, Weiping Zhou, Fang Wang, Shuhan Sun	2015	98
20	Plasma circular RNA panel to diagnose hepatitis B virus‐related hepatocellular carcinoma: A large‐scale, multicenter study International Journal of Cancer ·Jian Yu, Wen‐bing Ding, Meng‐chao Wang, Xinggang Guo, Jian Xu, Qingguo Xu, Yuan Yang, Shuhan Sun, Jing‐feng Liu, Lun–Xiu Qin, Hui Liu, Fu Yang, Weiping Zhou	2019	90

About Fu Yang

Fu Yang is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Immunology and Surgery, having authored 94 papers that have together received 8.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (33 papers), RNA modifications and cancer (32 papers), RNA Research and Splicing (15 papers), MicroRNA in disease regulation (14 papers), Circular RNAs in diseases (13 papers), Cancer-related gene regulation (7 papers), Hepatitis B Virus Studies (6 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Cancer Research (5.8k citations), Molecular Biology (6.7k citations), Biological Psychiatry (108 citations), Neurology (353 citations) and Hepatology (281 citations). Fu Yang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shuhan Sun, Weiping Zhou, Ji‐hang Yuan, Jinzhao Ma, Shengxian Yuan, Yuan Yang, Fang Wang, Chuanchuan Zhou, Xisong Huo and Qingguo Xu. Their work appears in journals such as Hepatology, Cell Death and Disease, Journal of Cellular Biochemistry, Cancer Letters and Molecular BioSystems.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Fu Yang

Impact in

Papers in i

In The Last Decade

Fu Yang

Fu Yang's Hit Papers

Peers

Countries citing papers authored by Fu Yang

Fields of papers citing papers by Fu Yang

All Works

About Fu Yang

Explore authors with similar magnitude of impact

Papers in